UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Stride
LRN
$3.34B
| $1.23M | ﹤0.01% |
39,386
-7,171
| -15% | -$263K |
|
1702
Rhythm Pharmaceuticals
RYTM
$7.96B
| $1.23M | ﹤0.01% |
42,197
+12,260
| +41% | +$315K |
|
1703
AMERISAFE
AMSF
$524M
| $1.23M | ﹤0.01% |
23,620
+1,809
| +8% | +$95.8K |
|
1704
Krystal Biotech
KRYS
$9.68B
| $1.23M | ﹤0.01% |
15,471
-701
| -4% | -$52K |
|
|
IMGN
1705
DELISTED
Immunogen Inc
IMGN
| $1.23M | ﹤0.01% |
247,079
+2,477
| +1% | +$13.4K |
|
|
AVID
1706
DELISTED
Avid Technology Inc
AVID
| $1.22M | ﹤0.01% |
45,959
-2,972
| -6% | -$78.2K |
|
1707
Jack in the Box
JACK
$338M
| $1.22M | ﹤0.01% |
17,892
-387
| -2% | -$29.7K |
|
1708
Tompkins Financial
TMP
$1.4B
| $1.22M | ﹤0.01% |
15,714
| – | – |
|
1709
St. Joe Company
JOE
$3.76B
| $1.22M | ﹤0.01% |
31,511
-627
| -2% | -$22.4K |
|
1710
Gibraltar Industries
ROCK
$1.45B
| $1.22M | ﹤0.01% |
26,500
| – | – |
|
1711
Core & Main
CNM
$8.67B
| $1.21M | ﹤0.01% |
62,847
+9,529
| +18% | +$203K |
|
1712
Peoples Bancorp
PEBO
$1.45B
| $1.21M | ﹤0.01% |
42,835
+4,203
| +11% | +$124K |
|
|
MNTV
1713
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.21M | ﹤0.01% |
172,770
+2,712
| +2% | +$19.6K |
|
1714
Orion
OEC
$395M
| $1.21M | ﹤0.01% |
67,661
+3,127
| +5% | +$52.6K |
|
1715
Newmark Group
NMRK
$2.53B
| $1.2M | ﹤0.01% |
150,881
| – | – |
|
1716
Cinemark Holdings
CNK
$4.34B
| $1.2M | ﹤0.01% |
138,717
+17,981
| +15% | +$203K |
|
|
COWN
1717
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.2M | ﹤0.01% |
31,047
-36
| -0.1% | -$1.39K |
|
|
CWEN.A
1718
DELISTED
Clearway Energy Class A
CWEN.A
| $1.2M | ﹤0.01% |
39,965
| – | – |
|
1719
La-Z-Boy
LZB
$1.66B
| $1.2M | ﹤0.01% |
52,374
-2,143
| -4% | -$52.1K |
|
1720
Palomar
PLMR
$3.45B
| $1.19M | ﹤0.01% |
26,410
+1,828
| +7% | +$125K |
|
1721
Core Laboratories
CLB
$549M
| $1.19M | ﹤0.01% |
58,804
+3,298
| +6% | +$63.9K |
|
1722
Petco
WOOF
$780M
| $1.19M | ﹤0.01% |
125,336
+2,486
| +2% | +$25.5K |
|
1723
StepStone Group
STEP
$3.83B
| $1.19M | ﹤0.01% |
47,165
| – | – |
|
1724
Payoneer
PAYO
$2.41B
| $1.19M | ﹤0.01% |
216,837
+2,303
| +1% | +$14.4K |
|
1725
Ligand Pharmaceuticals
LGND
$6.28B
| $1.18M | ﹤0.01% |
17,621
-10,625
| -38% | -$691K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.